STOCK TITAN
  1. Home
  2. News
  3. ONTX

Corgi ONTO 2x Daily ETF (ONTX) Stock News, May-Oct 2023

ONTX Nasdaq
News

Promising Preclinical Narazaciclib Data Presented at MCL Meeting

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.68%
Tags
none
-
News

Encouraging Rigosertib Data Presented at EADV as Late Breaker

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
none
-
News

Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
conferences
News

Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
conferences
-
News

Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.87%
Tags
earnings
-
News

Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.98%
Tags
earnings date
News

Onconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
clinical trial
-
News

Onconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meeting

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
none
-
News

Onconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
clinical trial
News

Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.24%
Tags
earnings

FAQ

What is the current stock price of Corgi ONTO 2x Daily ETF (ONTX)?

The current stock price of Corgi ONTO 2x Daily ETF (ONTX) is $20.4799 as of October 2, 2026.